Melanoma/Skin Cancer

Top Story

Melanoma rates decline among US adolescents, young adults

Melanoma rates decline among US adolescents, young adults
November 13, 2019
Meeting News

Off-the-shelf natural killer cells safe, clinically active for advanced Merkel cell carcinoma

November 8, 2019
NATIONAL HARBOR, Md. — Allogeneic activated natural killer cell therapy resulted in some antitumor activity with no serious side effects in patients with…

University of Chicago professor receives ESMO Award for Immuno-Oncology

November 7, 2019
Thomas Gajewski, MD, PhD, will receive this year's ESMO Award for Immuno-Oncology. The award recognizes Gajewski’s work exploring why some patients are
In the Journals

Region-growing algorithm performs best in melanoma classification using AI

November 7, 2019
The region-growing algorithm had the best segmentation performance in an assessment of the effectiveness of artificial intelligence methods for melanoma classification…
More Headlines »

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Bristol-Myers Squibb.

For patients diagnosed with metastatic melanoma, the lifetime incidence of brain metastasis is more than 50% and is…
More »
FDA News

VIDEO: BRAF-MEK combination represents ‘important new therapy’ for melanoma

June 27, 2018
More »
Resource Centers